Patient Note — 258474

4/21/26, 1:35 AM Print Preview [PATIENT_NAME] DOB: [DOB] (83 yo M) Acc No. [ACCOUNT_ID] DOS: 02/02/2026 Patient: [PATIENT_NAME] Provider: [PROVIDER_NAME], MD Account: [ACCOUNT_ID] DOB: [DOB] Age: 83 Y Sex: Male Date: 02/02/2026 Phone: Address: [ADDRESS], WOODBRIDGE, VA-[ZIP] Pcp: [PROVIDER_NAME] Subjective: Chief Complaints: 1. PAE CONSULT. HPI: ARTERA: 83-year-old male patient with a history of a. fib on AC, bladder stones s/p cystolitholapaxy [12/21/2025] and BPH with LUTS. Patient is currently taking tamsulosin 0.4 mg for BPH with LUTS without any symptomatic improvement. Patient endorses some hematuria in the urine. States there is occasional burning with urination and reports that sometimes the urine is not clear. Denies slow, weak stream. He endorses urinary urgency and frequency and x2 Nocturia. Cysto/TRUS (11/2025): trabeculation severe, multiple bladder stones, bullous edema, prostate trilobar enlargement (lateral + median), prostate volume: 234 grams. The patient has been referred by his Urologist to discuss potential minimally invasive treatment options. The patient is accompanied by his daughter on today's televisit consultation. Medical History: Hypertension, High cholesterol, Afib. Surgical History: cardiac ablation , colonoscopy , dental implant , Appendectomy . Hospitalization/Major Diagnostic Procedure: avs 2025. Screening: Medications: Taking Vitamin D 400 UNIT Capsule 2 capsules Orally Once a day , Taking Magnesium 300 MG Capsule 1 capsule with a meal Orally Once a day , Taking amLODIPine Besylate 2.5 MG Tablet Oral , Taking Lisinopril 10 MG Tablet Oral , Taking Atorvastatin Calcium 40 MG Tablet Oral , Taking Pantoprazole Sodium 40 MG Tablet Delayed Release Oral , Taking Xarelto(Rivaroxaban) 20 MG Tablet Oral , Taking Tamsulosin HCl 0.4 MG Capsule 1 capsule Orally Once a day , Taking Amoxicillin-Pot Clavulanate 875-125 MG Tablet 1 tablet Orally every 12 hrs , Not-Taking Rosuvastatin Calcium 40 MG Tablet Oral Objective: Vitals: Assessment: Assessment: 1. Benign prostatic hyperplasia with lower urinary tract symptoms - N40.1 (Primary) ASSESSMENT: The patient is a male with LUTS secondary to BPH, referred by Urology for evaluation and management options. We had an in-depth discussion of potential treatments, including surgical options, minimally invasive surgical therapies (MISTs), and PAE. The patient is considering PAE, but would like additional time to consider prior to proceeding. PLAN: 1. Treatment Plan: PAE was suggested as a minimally invasive treatment option. The patient was informed that PAE works by reducing blood flow to targeted prostatic tissue, leading to prostate gland shrinkage over 1 to 3 months post- procedure, with an expected success rate of approximately 90% in our practice. Provider: [PROVIDER_NAME], MD Date: 02/02/2026 Generated for Printing/Faxing/eTransmitting on: 04/21/2026 04:35 AM EDT 1/2 4/21/26, 1:35 AM Print Preview [PATIENT_NAME] DOB: [DOB] (83 yo M) Acc No. [ACCOUNT_ID] DOS: 02/02/2026 2. Risk an